Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TEJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,248
Award facts
- Contract value 100% obligated
- $96,248.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $96,248.29 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. The contract, which is not set aside for any specific business type, is scheduled for completion by January 12, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under Amerisourcebergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing a broad range of medications, vaccines, medical devices, and specialized healthcare commodities. Dupixent is a biologic medication used to treat conditions such as atopic dermatitis, asthma, and other allergic conditions, reflecting the contractor's role in providing specialty pharmaceuticals essential to military medical treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F3TEJ?
SPE2DR26F3TEJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F3TEJ worth?
The government has obligated $96,248 on SPE2DR26F3TEJ.
Is contract SPE2DR26F3TEJ an order under another contract?
Yes. SPE2DR26F3TEJ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TEJ competed?
The extent of competition for SPE2DR26F3TEJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award